Nonmyeloablative Stem Cell Transplantation Is an Effective Therapy for Refractory or Relapsed Hodgkin Lymphoma: Results of a Spanish Prospective Cooperative Protocol-Reference-Cited by-同舟云学术

Nonmyeloablative Stem Cell Transplantation Is an Effective Therapy for Refractory or Relapsed Hodgkin Lymphoma: Results of a Spanish Prospective Cooperative Protocol

Published:2006-02 Issue:2 Volume:12 Page:172-183
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Alvarez Iván,Sureda Anna,Caballero Maria D.,Urbano-Ispizua Alvaro,Ribera Josep M.,Canales Miguel,García-Conde Javier,Sanz Guillermo,Arranz Reyes,Bernal Maria T.,de la Serna Javier,Díez José L.,Moraleda José M.,Rubió-Félix Daniel,Xicoy Blanca,Martínez Carmen,Mateos Marivi V.,Sierra Jorge

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference38 articles.

1. BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin’s lymphoma;Diehl;J Clin Oncol,1998

2. Assessment of the Stanford V regimen and consolidative radiotherapy for bulky and advanced Hodgkin’s disease;Horning;J Clin Oncol,2000

3. Conventional dose salvage combination chemotherapy in patients relapsing with Hodgkin’s disease after combination chemotherapy;Longo;J Clin Oncol,1992

4. Outcome of patients with Hodgkin’s disease failing after primary MOPP-ABVD;Bonfante;J Clin Oncol,1997

5. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin’s disease;Linch;Lancet,1993

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TCR-α/β and CD19 depleted stem cell grafts from haploidentical donors for allogeneic transplantation in patients with relapsed lymphoma: a single-center experience;Leukemia & Lymphoma;2023-08-10

2. Outcomes of Patients With Classic Hodgkin Lymphoma Who Relapsed After Autologous Stem Cell Transplant;HemaSphere;2023-04

3. Advances in the treatment of Hodgkin lymphoma: Current and future approaches;Frontiers in Oncology;2023-03-03

4. Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents;Cancer Medicine;2023-01-18

5. Improved survival after single-unit cord blood transplantation using fludarabine and melphalan-based reduced-intensity conditioning for malignant lymphoma: impact of melphalan dose and graft-versus-host disease prophylaxis with mycophenolate mofetil;Annals of Hematology;2022-10-05